PGICX
Price
$18.50
Change
+$0.10 (+0.54%)
Updated
Jul 3 closing price
Net Assets
136.07M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

PGICX vs VVIAX

Header iconPGICX vs VVIAX Comparison
Open Charts PGICX vs VVIAXBanner chart's image
Virtus KAR Equity Income C
Price$18.50
Change+$0.10 (+0.54%)
VolumeN/A
Net Assets136.07M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
PGICX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PGICX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGICX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. PGICX (136M). PGICX pays higher dividends than VVIAX: PGICX (2.47) vs VVIAX (2.18). PGICX was incepted earlier than VVIAX: PGICX (28 years) vs VVIAX (25 years). PGICX (2.16) is less costly to investors than VVIAX (0.05). PGICX is a more actively managed with annual turnover of: 17.00 vs. VVIAX (9.00). PGICX has a lower initial minimum investment than VVIAX: PGICX (2500) vs VVIAX (3000). PGICX annual gain was more profitable for investors over the last year : 16.09 vs. VVIAX (12.03). VVIAX return over 5 years is better than : 80.13 vs. PGICX (7.58).
PGICXVVIAXPGICX / VVIAX
Total Expense Ratio1.950.053,900%
Annual Report Gross Expense Ratio2.160.054,320%
Fund Existence28 years25 years-
Gain YTD9.4036.198152%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets136M189B0%
Annual Yield % from dividends2.472.18113%
Returns for 1 year16.0912.03134%
Returns for 3 years14.5035.1741%
Returns for 5 years7.5880.139%
Returns for 10 years25.86115.6722%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.